These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27942591)

  • 1. mTOR inhibition and BMP signaling act synergistically to reduce muscle fibrosis and improve myofiber regeneration.
    Agarwal S; Cholok D; Loder S; Li J; Breuler C; Chung MT; Sung HH; Ranganathan K; Habbouche J; Drake J; Peterson J; Priest C; Li S; Mishina Y; Levi B
    JCI Insight; 2016 Dec; 1(20):e89805. PubMed ID: 27942591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
    Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
    Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Billings PC; Fiori JL; Bentwood JL; O'Connell MP; Jiao X; Nussbaum B; Caron RJ; Shore EM; Kaplan FS
    J Bone Miner Res; 2008 Mar; 23(3):305-13. PubMed ID: 17967130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of progenitor cells that contribute to heterotopic skeletogenesis.
    Lounev VY; Ramachandran R; Wosczyna MN; Yamamoto M; Maidment AD; Shore EM; Glaser DL; Goldhamer DJ; Kaplan FS
    J Bone Joint Surg Am; 2009 Mar; 91(3):652-63. PubMed ID: 19255227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis.
    Stanley A; Heo SJ; Mauck RL; Mourkioti F; Shore EM
    J Bone Miner Res; 2019 Oct; 34(10):1894-1909. PubMed ID: 31107558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
    de la Peña LS; Billings PC; Fiori JL; Ahn J; Kaplan FS; Shore EM
    J Bone Miner Res; 2005 Jul; 20(7):1168-76. PubMed ID: 15940369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.
    Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ
    J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?
    Wu J; Ren B; Shi F; Hua P; Lin H
    J Cell Biochem; 2019 Aug; 120(8):12108-12122. PubMed ID: 30989716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
    J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BMP signaling and bone formation].
    Katagiri T
    Clin Calcium; 2012 Nov; 22(11):1677-83. PubMed ID: 23103811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP type I receptor inhibition reduces heterotopic [corrected] ossification.
    Yu PB; Deng DY; Lai CS; Hong CC; Cuny GD; Bouxsein ML; Hong DW; McManus PM; Katagiri T; Sachidanandan C; Kamiya N; Fukuda T; Mishina Y; Peterson RT; Bloch KD
    Nat Med; 2008 Dec; 14(12):1363-9. PubMed ID: 19029982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva.
    Hino K; Horigome K; Nishio M; Komura S; Nagata S; Zhao C; Jin Y; Kawakami K; Yamada Y; Ohta A; Toguchida J; Ikeya M
    J Clin Invest; 2017 Sep; 127(9):3339-3352. PubMed ID: 28758906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
    Ravazzolo R; Cappato S; Bocciardi R
    Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva.
    de Vries TJ; Schoenmaker T; Micha D; Hogervorst J; Bouskla S; Forouzanfar T; Pals G; Netelenbos C; Eekhoff EMW; Bravenboer N
    Bone; 2018 Apr; 109():168-177. PubMed ID: 28705683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.
    Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype.
    Kan L; Hu M; Gomes WA; Kessler JA
    Am J Pathol; 2004 Oct; 165(4):1107-15. PubMed ID: 15466378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.
    Katagiri T; Tsukamoto S; Kuratani M
    Bone; 2018 Apr; 109():241-250. PubMed ID: 28754575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TGFβ signaling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease.
    Micha D; Voermans E; Eekhoff MEW; van Essen HW; Zandieh-Doulabi B; Netelenbos C; Rustemeyer T; Sistermans EA; Pals G; Bravenboer N
    Bone; 2016 Mar; 84():169-180. PubMed ID: 26769004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.
    Pacifici M
    Bone; 2018 Apr; 109():267-275. PubMed ID: 28826842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.